A5087643252- Acute Lymphoblastic Leukemia research
- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Multiple and Secondary Primary Cancers
- Chronic Lymphocytic Leukemia Research
- Cancer Treatment and Pharmacology
- Oral health in cancer treatment
- Multiple Myeloma Research and Treatments
- Vasculitis and related conditions
- Chronic Myeloid Leukemia Treatments
- Retinoids in leukemia and cellular processes
- Protein Degradation and Inhibitors
- Oral and Maxillofacial Pathology
- Inflammasome and immune disorders
- Heparin-Induced Thrombocytopenia and Thrombosis
- Healthcare during COVID-19 Pandemic
- Cardiac, Anesthesia and Surgical Outcomes
- Hemodynamic Monitoring and Therapy
- HIV/AIDS drug development and treatment
- Dermatological and COVID-19 studies
- Palliative and Oncologic Care
- Blood Pressure and Hypertension Studies
- Head and Neck Cancer Studies
- Antioxidant Activity and Oxidative Stress
- Oral Health Pathology and Treatment
Universidade Federal de Santa Catarina
2015-2021
Polydoro Ernani de São Thiago University Hospital
2020-2021
This study aimed to understand how patients perceive their oral health and the resulting manifestations of antineoplastic chemotherapy, as well analyze impact these alterations on health-related quality life. A total 80 undergoing treatment participated in this study. questionnaire was applied using Oral Health Impact Profile (OHIP-14) index open interviews. Items with highest prevalence included "worsened taste food sensation" (35.00%), "discomfort eating food" (20.00%), "feeling stressed"...
The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved response rates prolonged survival. Studies comparing different induction chemotherapy regimens shown that triple better results than double combinations. However, comparisons among are rare literature. We retrospectively compared two comprising bortezomib, cyclophosphamide dexamethasone (VCD) versus thalidomide, (CTD), aimed at identifying which would yield following...
Acute promyelocytic leukemia is a subtype of acute myeloid leukemia, characterized by the presence neoplastic promyelocytes, due to reciprocal balanced translocation between chromosomes 15 and 17. Currently, with use agents that act directly on this molecular change, such as all-trans retinoic acid arsenic trioxide, APL has shifted from highly mortal curable disease. However, some cases are still at high risk death, especially early acquiring better understanding clinical biological factors...
Burkitt lymphoma/leukemia (BL/L) is an aggressive oncohematological disease. This study evaluated the population-based prognosis and survival on BL/L as well if behaved a risk factor for development of second primary cancers (SPCs) other first tumors factors occurrence SPC. A retrospective cohort using Surveillance, Epidemiology End Results (SEER) Program (2008–2016) was performed. Kaplan–Meier, time-dependent covariate Cox regression Poisson models were conducted. Overall, 3094 patients...
A Constituição Brasileira, no artigo 207, expõe que as universidades devem obedecer ao princípio de indissociabilidade entre ensino, pesquisa e extensão. (BRASIL, 1988). Assim sendo, a Extensão Universitária denota prática acadêmica estabeleça uma postura da Universidade na sociedade em se insere. Seu papel é baseado um processo interdisciplinar, educativo, cultural, científico político, por meio do qual promove interação transforma não apenas Universidade, mas também os setores sociais com...
Os anticoagulantes orais diretos (AOD) surgiram como uma nova opção para pacientes que necessitam de anticoagulação eventos tromboembólicos tanto profiláticos quanto terapêuticos. Inúmeras vantagens os AODs possuem em relação aos convencionais, nas quais incluem o uso terapia alvo, sem necessidade controle com exames laboratoriais e interferência alimento. Também mostraram ser tão ou mais eficazes quando comparados convencionais. Porém, alguns podem apresentar intercorrência sangramento,...